Genko Oyama

Genko Oyama,

CO ASO PROF

Department: MD-NEUROLOGY-MOVEMENT DISORDER
Business Phone: (352) 273-5550
Business Email: genko@ufl.edu

Publications

2023
A defined method for differentiating human iPSCs into midbrain dopaminergic progenitors that safely restore motor deficits in Parkinson’s disease.
Frontiers in neuroscience. 17 [DOI] 10.3389/fnins.2023.1202027. [PMID] 37502682.
2023
Analytical and clinical validity of wearable, multi-sensor technology for assessment of motor function in patients with Parkinson’s disease in Japan.
Scientific reports. 13(1) [DOI] 10.1038/s41598-023-29382-6. [PMID] 36918552.
2023
Deep brain stimulation in posterior subthalamic area for Holmes tremor: Case reports with review of the literature.
Frontiers in neurology. 14 [DOI] 10.3389/fneur.2023.1139477. [PMID] 37034086.
2023
Long-Read Sequencing Resolves a Complex Structural Variant in PRKN Parkinson’s Disease.
Movement disorders : official journal of the Movement Disorder Society. 38(12):2249-2257 [DOI] 10.1002/mds.29610. [PMID] 37926948.
2023
Long-read sequencing resolves a complex structural variant in PRKN Parkinson’s disease.
medRxiv : the preprint server for health sciences. [DOI] 10.1101/2023.08.14.23293948. [PMID] 37790330.
2023
Role of the subthalamic nucleus in perceiving and estimating the passage of time.
Frontiers in aging neuroscience. 15 [DOI] 10.3389/fnagi.2023.1090052. [PMID] 36936495.
2023
Three-dimensional gait analysis of the effect of directional steering on gait in patients with Parkinson’s disease.
Parkinsonism & related disorders. 114 [DOI] 10.1016/j.parkreldis.2023.105770. [PMID] 37499354.
2022
Can AI make people happy? The effect of AI-based chatbot on smile and speech in Parkinson’s disease.
Parkinsonism & related disorders. 99:43-46 [DOI] 10.1016/j.parkreldis.2022.04.018. [PMID] 35596975.
2022
Continuous 24-h Levodopa-Carbidopa Intestinal Gel Infusion After a Levodopa Holiday Suppressed Refractory Dyskinesia Despite Increasing Levodopa Dose.
Journal of movement disorders. 15(3):290-292 [DOI] 10.14802/jmd.22021. [PMID] 35880379.
2022
Current Status of Telemedicine for Parkinson’s Disease in Japan: A Single-Center Cross-Sectional Questionnaire Survey.
Journal of movement disorders. 15(1):58-61 [DOI] 10.14802/jmd.21096. [PMID] 34937160.
2022
Deep Brain Stimulation for a Patient with Familial Parkinson’s Disease Harboring CHCHD2 p.T61I.
Movement disorders clinical practice. 9(3):407-409 [DOI] 10.1002/mdc3.13428. [PMID] 35402650.
2022
Genotype-phenotype correlation of Parkinson’s disease with PRKN variants.
Neurobiology of aging. 114:117-128 [DOI] 10.1016/j.neurobiolaging.2021.12.014. [PMID] 35123805.
2022
Impaired virtual space-tilting perception in Parkinson’s disease with Pisa syndrome.
Parkinsonism & related disorders. 104:30-34 [DOI] 10.1016/j.parkreldis.2022.09.002. [PMID] 36208613.
2022
Investigating the efficacy and safety of elobixibat, an ileal bile acid transporter inhibitor, in patients with Parkinson’s disease with chronic constipation: a multicentre, placebo-controlled, randomised, double-blind, parallel-group stud (CONST-PD).
BMJ open. 12(2) [DOI] 10.1136/bmjopen-2021-054129. [PMID] 35149566.
2022
Prevalence and characteristics of dry eye disease in Parkinson’s disease: a systematic review and meta-analysis.
Scientific reports. 12(1) [DOI] 10.1038/s41598-022-22037-y. [PMID] 36319814.
2022
Proceedings of the Ninth Annual Deep Brain Stimulation Think Tank: Advances in Cutting Edge Technologies, Artificial Intelligence, Neuromodulation, Neuroethics, Pain, Interventional Psychiatry, Epilepsy, and Traumatic Brain Injury.
Frontiers in human neuroscience. 16 [DOI] 10.3389/fnhum.2022.813387. [PMID] 35308605.
2022
Short-Term Motor Outcomes in Parkinson’s Disease after Subthalamic Nucleus Deep Brain Stimulation Combined with Post-Operative Rehabilitation: A Pre-Post Comparison Study.
Parkinson's disease. 2022 [DOI] 10.1155/2022/8448638. [PMID] 35992727.
2022
Subthalamic deep brain stimulation in Parkinson’s disease with SNCA mutations: Based on the follow-up to 10 years.
Brain and behavior. 12(2) [DOI] 10.1002/brb3.2503. [PMID] 35040589.
2022
White matter microstructures in Parkinson’s disease with and without impulse control behaviors.
Annals of clinical and translational neurology. 9(3):253-263 [DOI] 10.1002/acn3.51504. [PMID] 35137566.
2021
Clinical manifestations of Parkinson’s disease harboring VPS35 retromer complex component p.D620N with long-term follow-up.
Parkinsonism & related disorders. 84:139-143 [DOI] 10.1016/j.parkreldis.2021.02.014. [PMID] 33611076.
2021
Closed-loop programming using external responses for deep brain stimulation in Parkinson’s disease.
Parkinsonism & related disorders. 84:47-51 [DOI] 10.1016/j.parkreldis.2021.01.023. [PMID] 33556765.
2021
Intrajejunal Infusion of Levodopa/Carbidopa for Advanced Parkinson’s Disease: A Systematic Review.
Movement disorders : official journal of the Movement Disorder Society. 36(8):1759-1771 [DOI] 10.1002/mds.28595. [PMID] 33899262.
2021
New modalities and directions for dystonia care.
Journal of neural transmission (Vienna, Austria : 1996). 128(4):559-565 [DOI] 10.1007/s00702-020-02278-9. [PMID] 33389184.
2021
Varicella-zoster virus encephalitis resembling herpes simplex virus encephalitis.
BMJ case reports. 14(12) [DOI] 10.1136/bcr-2021-247602. [PMID] 34972787.
2021
White matter alterations in Parkinson’s disease with levodopa-induced dyskinesia.
Parkinsonism & related disorders. 90:8-14 [DOI] 10.1016/j.parkreldis.2021.07.021. [PMID] 34325387.
2021
White matter and nigral alterations in multiple system atrophy-parkinsonian type.
NPJ Parkinson's disease. 7(1) [DOI] 10.1038/s41531-021-00236-0. [PMID] 34716335.
2020
[Telemedicine in Neurological Diseases].
Brain and nerve = Shinkei kenkyu no shinpo. 72(10):1057-1060 [DOI] 10.11477/mf.1416201648. [PMID] 33051392.
2020
A Retrospective Imaging Evaluation of Presynaptic Dopaminergic Degeneration in Multiple System Atrophy with Levodopa Induced Dyskinesia.
Tremor and other hyperkinetic movements (New York, N.Y.). 10 [DOI] 10.5334/tohm.58. [PMID] 32775020.
2020
An International Survey of Deep Brain Stimulation Utilization in Asia and Oceania: The DBS Think Tank East.
Frontiers in human neuroscience. 14 [DOI] 10.3389/fnhum.2020.00162. [PMID] 32733215.
2020
Clinical characterization of patients with leucine-rich repeat kinase 2 genetic variants in Japan.
Journal of human genetics. 65(9):771-781 [DOI] 10.1038/s10038-020-0772-4. [PMID] 32398759.
2020
Evaluation of white matter microstructure in patients with Parkinson’s disease using microscopic fractional anisotropy.
Neuroradiology. 62(2):197-203 [DOI] 10.1007/s00234-019-02301-1. [PMID] 31680195.
2020
Graphic Summary of Movement Disorders Society Criteria for Progressive Supranuclear Palsy and Multiple Allocations eXtinction Rules.
Movement disorders clinical practice. 7(2):240-242 [DOI] 10.1002/mdc3.12894. [PMID] 32071951.
2020
Holomedicine: Proof of the Concept of Interactive Three-Dimensional Telemedicine.
Movement disorders : official journal of the Movement Disorder Society. 35(10):1719-1720 [DOI] 10.1002/mds.28249. [PMID] 32926470.
2020
Neurocognitive and psychiatric disorders-related axonal degeneration in Parkinson’s disease.
Journal of neuroscience research. 98(5):936-949 [DOI] 10.1002/jnr.24584. [PMID] 32026517.
2020
Neuroimaging evaluation and successful treatment by using directional deep brain stimulation and levodopa in a patient with GNAO1-associated movement disorder: A case report.
Journal of the neurological sciences. 411 [DOI] 10.1016/j.jns.2020.116710. [PMID] 32044685.
2020
Reduced astrocytic reactivity in human brains and midbrain organoids with PRKN mutations.
NPJ Parkinson's disease. 6(1) [DOI] 10.1038/s41531-020-00137-8. [PMID] 33298969.
2020
Rescue Levodopa/Carbidopa Intestinal Gel for Secondary Deep Brain Stimulation Failure.
Journal of movement disorders. 13(1):57-61 [DOI] 10.14802/jmd.19051. [PMID] 31986869.
2020
The absence of orthostatic heart rate increase is associated with cognitive impairment in Parkinson’s disease.
PloS one. 15(10) [DOI] 10.1371/journal.pone.0240491. [PMID] 33057432.
2020
Young age and severity of motor function are risk factors for psychosis after subthalamic nucleus deep brain stimulation for Parkinson’s disease.
Psychiatry and clinical neurosciences. 74(5):328-329 [DOI] 10.1111/pcn.12991. [PMID] 32057166.
2019
A Randomized Crossover Pilot Study of Telemedicine Delivered via iPads in Parkinson’s Disease.
Parkinson's disease. 2019 [DOI] 10.1155/2019/9403295. [PMID] 30723541.
2019
Balance and Gait Improvements of Postoperative Rehabilitation in Patients with Parkinson’s Disease Treated with Subthalamic Nucleus Deep Brain Stimulation (STN-DBS).
Parkinson's disease. 2019 [DOI] 10.1155/2019/7104071. [PMID] 31467660.
2019
Convolutional neural network-based segmentation can help in assessing the substantia nigra in neuromelanin MRI.
Neuroradiology. 61(12):1387-1395 [DOI] 10.1007/s00234-019-02279-w. [PMID] 31401723.
2019
Free-Water Imaging in White and Gray Matter in Parkinson’s Disease.
Cells. 8(8) [DOI] 10.3390/cells8080839. [PMID] 31387313.
2019
Pilot feasibility study of a semi-automated three-dimensional scoring system for cervical dystonia.
PloS one. 14(8) [DOI] 10.1371/journal.pone.0219758. [PMID] 31393884.
2019
Technique and outcome of percutaneous endoscopic transgastric jejunostomy for continuous infusion of levodopa-carbidopa intestinal gel for treatment of Parkinson’s disease.
Scandinavian journal of gastroenterology. 54(6):787-792 [DOI] 10.1080/00365521.2019.1619830. [PMID] 31125265.
2018
A Japanese family with mutation in the proteinase inhibitor 12 L47P gene: A case report.
Journal of the neurological sciences. 384:126-128 [DOI] 10.1016/j.jns.2017.11.029. [PMID] 29249370.
2018
Association between abnormal nocturnal blood pressure profile and dementia in Parkinson’s disease.
Parkinsonism & related disorders. 46:24-29 [DOI] 10.1016/j.parkreldis.2017.10.014. [PMID] 29126762.
2018
Cerebral microbleeds and blood pressure abnormalities in Parkinson’s disease.
eNeurologicalSci. 10:5-11 [DOI] 10.1016/j.ensci.2017.12.002. [PMID] 29736422.
2018
Dopamine transporter imaging predicts motor responsiveness to levodopa challenge in patients with Parkinson’s disease: A pilot study of DATSCAN for subthalamic deep brain stimulation.
Journal of the neurological sciences. 385:134-139 [DOI] 10.1016/j.jns.2017.12.030. [PMID] 29406893.
2018
Effect of subthalamic nucleus deep brain stimulation on visual scanning.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology. 129(11):2421-2432 [DOI] 10.1016/j.clinph.2018.08.003. [PMID] 30292079.
2018
GCH1 mutations in dopa-responsive dystonia and Parkinson’s disease.
Journal of neurology. 265(8):1860-1870 [DOI] 10.1007/s00415-018-8930-8. [PMID] 29948246.
2018
Istradefylline for Restless Legs Syndrome Associated with Parkinson’s Disease.
Tremor and other hyperkinetic movements (New York, N.Y.). 8 [DOI] 10.7916/D86H5R1H. [PMID] 29423337.
2018
Pilot Study of a Device to Induce the Hanger Reflex in Patients with Cervical Dystonia.
Neurologia medico-chirurgica. 58(5):206-211 [DOI] 10.2176/nmc.oa.2017-0111. [PMID] 29607887.
2018
Randomized, double-blind, multicenter trial of hydrogen water for Parkinson’s disease.
Movement disorders : official journal of the Movement Disorder Society. 33(9):1505-1507 [DOI] 10.1002/mds.27472. [PMID] 30207619.
2018
The presence of cerebral microbleeds is associated with cognitive impairment in Parkinson’s disease.
Journal of the neurological sciences. 393:39-44 [DOI] 10.1016/j.jns.2018.08.009. [PMID] 30103062.
2018
Transdermal rotigotine patch in Parkinson’s disease with a history of intestinal operation.
BMJ case reports. 2018 [DOI] 10.1136/bcr-2017-223722. [PMID] 29909386.
2018
Zonisamide Administration Improves Fatty Acid β-Oxidation in Parkinson’s Disease.
Cells. 8(1) [DOI] 10.3390/cells8010014. [PMID] 30597973.
2017
[Deep Brain Stimulation for Parkinson Disease:Mechanisms and New Technology].
No shinkei geka. Neurological surgery. 45(1):5-14 [DOI] 10.11477/mf.1436203439. [PMID] 28100856.
2017
A novel mutation of CHCHD2 p.R8H in a sporadic case of Parkinson’s disease.
Parkinsonism & related disorders. 34:66-68 [DOI] 10.1016/j.parkreldis.2016.10.018. [PMID] 28341223.
2017
Deep brain stimulation for Parkinson’s disease.
Nihon rinsho. Japanese journal of clinical medicine. 75(1):83-88 [PMID] 30566299.
2017
Erratum to: A randomized double-blind multi-center trial of hydrogen water for Parkinson’s disease: protocol and baseline characteristics.
BMC neurology. 17(1) [DOI] 10.1186/s12883-017-0817-2. [PMID] 28219346.
2017
Management of impulse control disorders with deep brain stimulation: A double-edged sword.
Journal of the neurological sciences. 374:63-68 [DOI] 10.1016/j.jns.2017.01.019. [PMID] 28126343.
2017
Postoperative lead migration in deep brain stimulation surgery: Incidence, risk factors, and clinical impact.
PloS one. 12(9) [DOI] 10.1371/journal.pone.0183711. [PMID] 28902876.
2016
A randomized double-blind multi-center trial of hydrogen water for Parkinson’s disease: protocol and baseline characteristics.
BMC neurology. 16 [DOI] 10.1186/s12883-016-0589-0. [PMID] 27176725.
2016
Atypical parkinsonism caused by Pro105Leu mutation of prion protein: A broad clinical spectrum.
Neurology. Genetics. 2(1) [DOI] 10.1212/NXG.0000000000000048. [PMID] 27066585.
2016
Current Topics in Deep Brain Stimulation for Parkinson Disease.
Neurologia medico-chirurgica. 56(10):613-625 [PMID] 27349658.
2015
Alleviation of myoclonus after bilateral pallidal deep brain stimulation for Lance-Adams syndrome.
Journal of neurology. 262(6):1581-3 [DOI] 10.1007/s00415-015-7748-x. [PMID] 25929661.
2015
High frequency of beta-propeller protein-associated neurodegeneration (BPAN) among patients with intellectual disability and young-onset parkinsonism.
Neurobiology of aging. 36(5):2004.e9-2004.e15 [DOI] 10.1016/j.neurobiolaging.2015.01.020. [PMID] 25744623.
2015
Low-frequency versus high-frequency subthalamic nucleus deep brain stimulation on postural control and gait in Parkinson’s disease: a quantitative study.
Brain stimulation. 8(1):64-75 [DOI] 10.1016/j.brs.2014.10.011. [PMID] 25440578.
2014
Brittle Dyskinesia Following STN but not GPi Deep Brain Stimulation.
Tremor and other hyperkinetic movements (New York, N.Y.). 4 [DOI] 10.7916/D8KS6PPR. [PMID] 24932426.
2014
Deep brain stimulation for tremor associated with underlying ataxia syndromes: a case series and discussion of issues.
Tremor and other hyperkinetic movements (New York, N.Y.). 4 [DOI] 10.7916/D8542KQ5. [PMID] 25120941.
2014
Deep brain stimulation may improve quality of life in people with Parkinson’s disease without affecting caregiver burden.
Neuromodulation : journal of the International Neuromodulation Society. 17(2):126-32 [PMID] 24024760.
2014
Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson’s disease.
Neurobiology of aging. 35(11):2656.e17-2656.e23 [DOI] 10.1016/j.neurobiolaging.2014.05.025. [PMID] 24973808.
2014
Posterior subthalamic area deep brain stimulation for fragile X-associated tremor/ataxia syndrome.
Neuromodulation : journal of the International Neuromodulation Society. 17(8):721-3 [DOI] 10.1111/ner.12150. [PMID] 24528808.
2014
Rescue GPi-DBS for a Stroke-associated Hemiballism in a Patient with STN-DBS.
Tremor and other hyperkinetic movements (New York, N.Y.). 4 [DOI] 10.7916/D8XP72WF. [PMID] 24587970.
2014
Subthalamic deep brain stimulation for a Parkinson’s disease patient with duplication of SNCA.
Neuromodulation : journal of the International Neuromodulation Society. 17(1):102-3 [DOI] 10.1111/ner.12034. [PMID] 23441980.
2013
[Mechanism of action for deep brain stimulation and electrical neuro-network modulation (ENM)].
Rinsho shinkeigaku = Clinical neurology. 53(9):691-4 [PMID] 24097315.
2013
[Update on deep brain stimulation for movement disorders].
Rinsho shinkeigaku = Clinical neurology. 53(11):911-4 [PMID] 24291831.
2013
A Novel DYT-5 Mutation with Phenotypic Variability within a Colombian Family.
Tremor and other hyperkinetic movements (New York, N.Y.). 3 [DOI] 10.7916/D86W98SW. [PMID] 24255805.
2013
Differential and better response to deep brain stimulation of chorea compared to dystonia in Huntington’s disease.
Stereotactic and functional neurosurgery. 91(2):129-33 [DOI] 10.1159/000341070. [PMID] 23343665.
2013
Efficacy and safety of a once-daily extended-release formulation of pramipexole switched from an immediate-release formulation in patients with advanced Parkinson’s disease: results from an open-label study.
Drug research. 63(12):639-43 [DOI] 10.1055/s-0033-1351257. [PMID] 23884661.
2013
Standard strategies for diagnosis and treatment of patients with newly diagnosed Parkinson disease: JAPAN.
Neurology. Clinical practice. 3(6):477-478 [DOI] 10.1212/01.CPJ.0000437021.22294.25. [PMID] 30123690.
2013
Taking a better history for behavioral issues pre- and post-deep brain stimulation: issues missed by standardized scales.
Neuromodulation : journal of the International Neuromodulation Society. 16(1):35-9; discussion 39 [DOI] 10.1111/j.1525-1403.2012.00477.x. [PMID] 22748071.
2013
Validity of single tract microelectrode recording in subthalamic nucleus stimulation.
Neurologia medico-chirurgica. 53(11):821-7 [PMID] 24140767.
2012
Addiction-like manifestations and Parkinson’s disease: a large single center 9-year experience.
The International journal of neuroscience. 122(3):145-53 [DOI] 10.3109/00207454.2011.633722. [PMID] 22023411.
2012
Are selective serotonin reuptake inhibitors associated with greater apathy in Parkinson’s disease?
The Journal of neuropsychiatry and clinical neurosciences. 24(3):326-30 [DOI] 10.1176/appi.neuropsych.11090210. [PMID] 23037646.
2012
Effects of STN and GPi deep brain stimulation on impulse control disorders and dopamine dysregulation syndrome.
PloS one. 7(1) [DOI] 10.1371/journal.pone.0029768. [PMID] 22295068.
2012
GPi and STN deep brain stimulation can suppress dyskinesia in Parkinson’s disease.
Parkinsonism & related disorders. 18(7):814-8 [DOI] 10.1016/j.parkreldis.2012.03.022. [PMID] 22525365.
2012
Low-Frequency Deep Brain Stimulation for Dystonia: Lower is Not Always Better.
Tremor and other hyperkinetic movements (New York, N.Y.). 2 [DOI] 10.7916/D85X27PH. [PMID] 23450104.
2012
Selection of deep brain stimulation candidates in private neurology practices: referral may be simpler than a computerized triage system.
Neuromodulation : journal of the International Neuromodulation Society. 15(3):246-50; discussion 250 [DOI] 10.1111/j.1525-1403.2012.00437.x. [PMID] 22376158.
2011
Acute effects of bilateral subthalamic stimulation on decision-making in Parkinson’s disease.
Parkinsonism & related disorders. 17(3):189-93 [DOI] 10.1016/j.parkreldis.2010.12.004. [PMID] 21276745.
2011
Delayed clinical improvement after deep brain stimulation-related subdural hematoma. Report of 4 cases.
Journal of neurosurgery. 115(2):289-94 [DOI] 10.3171/2011.3.JNS101424. [PMID] 21476805.
2011
Effect of Deep Brain Stimulation on Parkinson’s Nonmotor Symptoms following Unilateral DBS: A Pilot Study.
Parkinson's disease. 2011 [DOI] 10.4061/2011/507416. [PMID] 22220288.
2011
Mixed results for GPi-DBS in the treatment of cranio-facial and cranio-cervical dystonia symptoms.
Journal of neurology. 258(11):2069-74 [DOI] 10.1007/s00415-011-6075-0. [PMID] 21553081.
2011
Paroxysmal Kinesigenic Dyskinesia-like Symptoms in a Patient with Tourette Syndrome.
Tremor and other hyperkinetic movements (New York, N.Y.). 1 [DOI] 10.7916/D8XG9PWK. [PMID] 23440654.
2011
Pre- and post- GPi DBS neuropsychological profiles in a case of X-linked dystonia-Parkinsonism.
The Clinical neuropsychologist. 25(1):141-59 [DOI] 10.1080/13854046.2010.532812. [PMID] 21253963.
2011
Rescue leads: a salvage technique for selected patients with a suboptimal response to standard DBS therapy.
Parkinsonism & related disorders. 17(6):451-5 [DOI] 10.1016/j.parkreldis.2011.03.009. [PMID] 21482169.
2011
Steady or not following thalamic deep brain stimulation for essential tremor.
Journal of neurology. 258(9):1643-8 [DOI] 10.1007/s00415-011-5986-0. [PMID] 21442464.
2011
The distal partial trisomy 1q syndrome and dystonic tremor.
Parkinsonism & related disorders. 17(2):128-9 [DOI] 10.1016/j.parkreldis.2010.10.004. [PMID] 21044857.
2011
The Frequency of Nonmotor Symptoms among Advanced Parkinson Patients May Depend on Instrument Used for Assessment.
Parkinson's disease. 2011 [DOI] 10.4061/2011/290195. [PMID] 21808724.
2011
Unilateral deep brain stimulation surgery in Parkinson’s disease improves ipsilateral symptoms regardless of laterality.
Parkinsonism & related disorders. 17(10):745-8 [DOI] 10.1016/j.parkreldis.2011.07.010. [PMID] 21856205.
2011
Unilateral GPi-DBS as a treatment for levodopa-induced respiratory dyskinesia in Parkinson disease.
The neurologist. 17(5):282-5 [DOI] 10.1097/NRL.0b013e318217367b. [PMID] 21881473.
2010
Differential response of dystonia and parkinsonism following globus pallidus internus deep brain stimulation in X-linked dystonia-parkinsonism (Lubag).
Stereotactic and functional neurosurgery. 88(5):329-33 [DOI] 10.1159/000319961. [PMID] 20714213.
2010
Impaired in vivo dopamine release in parkin knockout mice.
Brain research. 1352:214-22 [DOI] 10.1016/j.brainres.2010.06.065. [PMID] 20620130.
2009
Mechanism and treatment of dropped head syndrome associated with parkinsonism.
Parkinsonism & related disorders. 15(3):181-6 [DOI] 10.1016/j.parkreldis.2008.04.040. [PMID] 18573677.
2009
Subsecond reward-related dopamine release in the mouse dorsal striatum.
Neuroscience research. 63(4):267-72 [PMID] 19367786.
2007
Fabrication, characterization, and application of boron-doped diamond microelectrodes for in vivo dopamine detection.
Analytical chemistry. 79(22):8608-15 [PMID] 17918970.
2005
[Familial amyotrophic lateral sclerosis with rapid progression].
No to shinkei = Brain and nerve. 57(11):1003-6 [PMID] 16363640.

Contact Details

Phones:
Business:
(352) 273-5550
Emails:
Business:
genko@ufl.edu
Addresses:
Business Mailing:
PO Box 100236
GAINESVILLE FL 32610
Business Street:
PO Box 100236
GAINESVILLE FL 32610